Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 15, 2024 02:00 ET | Source: Karolinska Development AB (publ)

Delårsrapport för januari – september 2024

STOCKHOLM – den 15 november 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) publicerar idag sin delårsrapport för januari – september 2024. Den fulla rapporten är tillgänglig på bolagets...
November 15, 2024 02:00 ET | Source: Karolinska Development AB (publ)

Interim Report - January-September 2024

STOCKHOLM – 15 November 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Interim Report - January-September 2024. The full report is available on the Company's website. ...
November 13, 2024 06:20 ET | Source: Karolinska Development AB (publ)

Karolinska Developments extra bolagsstämma 2024

STOCKHOLM, SVERIGE – 13 november 2024. Karolinska Development AB (publ) (”Karolinska Development” eller ”Bolaget”) har den 13 november 2024 hållit extra bolagsstämma, varvid aktieägarna beslutade...
November 13, 2024 06:20 ET | Source: Karolinska Development AB (publ)

Karolinska Development’s Extraordinary General Meeting 2024

STOCKHOLM, SWEDEN – November 13, 2024. Karolinska Development AB (publ) (“Karolinska Development” or the “Company”) held an Extraordinary General Meeting on November 13, 2024, at which the...
November 05, 2024 02:15 ET | Source: Karolinska Development AB (publ)

Karolinska Developments portföljbolag BOOST Pharma har genomfört ett framgångsrikt FDA-möte och erhåller andra delen av tidigare avtalad investering

STOCKHOLM, SVERIGE, 5 november 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget BOOST Pharma framgångsrikt har genomfört ett rådgivande möte, så kallat...
November 05, 2024 02:15 ET | Source: Karolinska Development AB (publ)

Karolinska Development’s portfolio company BOOST Pharma successfully completes pre-IND meeting with FDA and receives second tranche of investment

STOCKHOLM, SWEDEN, November 5 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company BOOST Pharma has succesfully completed a pre-IND meeting with the U.S....
October 21, 2024 07:43 ET | Source: Karolinska Development AB (publ)

Karolinska Developments portföljbolag SVF Vaccines presenterar positiva data från en fas 1-studie med bolagets universella vaccin mot covid-19

STOCKHOLM, SVERIGE, 21 oktober 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget SVF Vaccines har presenterat positiva kliniska säkerhets- och...
October 21, 2024 07:43 ET | Source: Karolinska Development AB (publ)

Karolinska Development’s portfolio company SVF Vaccines announces positive data from a phase 1 study of its universal Covid-19 vaccine

STOCKHOLM, SWEDEN, October 21, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines, has presented positive clinical safety and immunogenicity...
October 17, 2024 02:50 ET | Source: Karolinska Development AB (publ)

Karolinska Developments portföljbolag Umecrine Cognition presenterar nya prekliniska Parkinsondata för golexanolon på den vetenskapliga konferensen INBC 2024

STOCKHOLM, SVERIGE, 17 oktober 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar att portföljbolaget Umecrine Cognition kommer att presentera nya prekliniska data för golexanolon som...
October 17, 2024 02:50 ET | Source: Karolinska Development AB (publ)

Karolinska Development’s portfolio company Umecrine Cognition presents new preclinical Parkinson’s data on golexanolone at the scientific conference, INBC 2024

STOCKHOLM, SWEDEN – October 17, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition will present new preclinical data on...